tirzepatide cvot results In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx Can Dual Incretin Receptor Agonists

According to Truveta, a clinical data analysis company, more than 120,000 patients received a first-time GLP-1 prescription for either Mounjaro, Ozempic, or Wegovy between January 2020 and April 2023

Tirzepatide drugs like Zepbound continue to cause severe injuries, like vision loss, pancreatitis, blood clots, and a range of serious gastrointestinal injuries, in some patients

Finish your free check Real seniors

Your dose is personalized to you and adjusted over time

Tirzepatide injection is simple to use if pre-prepped via branded, self-administered brands and can be done at home

Why direct conversion is problematic Semaglutide and tirzepatide have different receptor binding profiles, different potencies at the GLP-1 receptor, and tirzepatide has an additional receptor target entirely